Anaplastic lymphoma kinase modulators and methods of use
Details for Australian Patent Application No. 2005230847 (hide)
International Classifications
Event Publications
5 October 2006 PCT application entered the National Phase
PCT publication WO2005/097765 Priority application(s): WO2005/097765
9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
16 September 2010 Section 223 Application Received
Exelixis, Inc. An application to extend the time from 05 Mar 2009 to 05 Apr 2010 in which to request examination has been filed . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2006
4 November 2010 Section 223 Application Allowed
Exelixis, Inc. The time in which to request examination has been extended to 05 Apr 2010. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005230848-Humanized anti-TGF-beta antibodies
2005230846-2-aminomethylthiazole-5-carboxamides as protein kinase modulators
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser